A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers
Clinical trial NCT03099824 · COMPLETED
Trial details
- NCT number
- NCT03099824
- Sponsor
- Galera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2020-01-27
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.